https://www.selleckchem.com/GSK-3.html
ion, and more studies are warranted to validate our findings and to clarify underlying mechanisms. Due to their health condition, patients with neuromuscular diseases (NMD) are at greater risk of developing serious complications with COVID-19. The objective of this study was to analyze the prevalence of COVID-19 among NMD patients and the risk factors for its impact and severity during the first wave of the pandemic. Clinical data were collected from NMD-COVID-19 patients, between March 25, 2020 and May 11, 2020 in an anonymous survey carried out
Mi piace
Commento
Condividi
